Basics of , Major Techniques for Separation of and Overview of Chiral Separation Systems

Bezhan Chankvetadze Seminar Topics

Basics of stereochemistry, production of enantiomerically pure compounds and enantioselective analysis

Analytical and preparative-scale liquid-phase separation of enantiomers

Scientific background behind the development of Lux series of chiral columns for HPLC enantioseparations

Overview of currently available columns of Lux series for chiral HPLC separations Basics of Stereochemistry

Definition of Stereoisomers (enantiomers and ) Stereogenic center Axial, planar and helical chirality Topological chirality/Chiral objects

Relevance of chirality to biological activity of chemical compounds

Chiral drugs

Comparative description of methods for preparation of enantiomerically pure chiral compounds

Analytical methods for evaluation of enantiomeric purity of chiral compounds Types of isomers

Constitutional isomers

Cis-trans/geometric isomers

Stereoisomers Diastereoisomers Meso isomers Enantiomers Definition of chiral

A chiral is a type of molecule that lacks an internal plane of symmetry and has a non- superimposable mirror image.

The feature that is most often the cause of chirality in molecules is the presence of an asymmetric center. Enantiomers and Diastereomers

• Stereoisomers contain the same atoms with the same connectivity but with different orientation in space. • Stereoisomers which relate to each other as the mirror images are enantiomers. • Stereisomers which do not relate to each other as the mirror images are diastereomers. • Diastereomers can be resolved by using achiral stationary phases while for separation of enantiomers a chiral stationary phase (CSP) must be used.

• The sign of depends on the solvent used, sample concentration, wavelength, etc. and does not directly relate to the absolute stereochemical configuration of a chiral compound. Cahn-Ingold-Prelog (CIP) Nomenclature

R rectus right S sinister left

Br>Cl>F>H

CL CL

H H

Br F F Br R Fluorochlorobromoethane S

Carbon atom as a center of chirality

OH O NH2 Cl NH * C(CH3)3 HN * C2H5 H N 2 O Cl

Br

CO2CH3 CH3 NH C3H7 CH3 S C N * N * NH CH 3 O CH3 Nitrogen atom as a center of chirality

N CH3

H3C N

Troger ´s Base Sulfur atom as a center of chirality

O

O S S * O * C NH O C 2

O 2-(Benzylsulfinyl)benzamide Benzyl 2-(benzylsulfinyl)benzoic acid benzyl ester

H O O

O S N S C CH N * * 2 NH2 N H3CO

H C CH 6. 3 3 2-(Phenylsulfinyl)ethylamide O CH Omeprazole 3 Phosphor atom as a center of chirality

O Cl-C H -CH 2 2 O N P

Cl-C H 2-CH 2 N * H Cyclophosphamide

O Cl-C H -CH 2 2 O N P Trofosfamide Cl-C H -CH 2 2 * N

CH 2-CH 2-Cl

O Cl-C H -CH 2 2 O N P Iphosphamide H * N CH 2-CH 2-Cl

A B CH3 H3C

OH OH

D NO H N C 2 2 2,2‘-Dimethyl-6-amino-6´- Axis of chirality 1,1´-Binaphthyl-2,2´-diol nitrobiphenyl

were discovered in 1922 • a Greak for not , tropos rotation Helicenes

Hexahelicene Spirocompounds

OO H3C CH3

6,6 ´-Dimethyl-2,2 ´-spirobichromane O

O Di(naphthylcyclopentylketone)

SpiraLatin for twist or whorl Planar Chirality

• Cyclophans, Ansacompounds, Metallocens

CO H 2 Cr(CO)3

O O

CH3 CH2 CH2

CH3

(CH2)6 H3C Topological Chirality

• Catenanes, Rotaxanes, Knots • Macromolecular chirality • Chirality on the level of objects Helix Helixes in Nature

Chirality of Objects Chirality of Objects Ketotifen

Systematic ( IUPAC ) name 4-(1-methylpiperidin-4-ylidene)-4,9-dihydro-10 H-benzo[4,5]cyclohepta[1,2- b]thiophen-10-one DAD1 A, Sig=220,4 Ref=off (C1-1- BASE...2-280311\PHENOMENEX-BASE-SP-TOTAL 2011-03-28 15-09-49\032-1601.D) mAU 69 1200 90. 38 85

5.354 : 13. a 85 Are : a Lux Cellulose-1

5.964 Are 1000 n-Hex/EtOH/DEA=80/20/0.1 800 v/v/v, 1 ml/min

600

400

200

0

0 2 4 6 8 10 12 14 min Basics of Stereochemistry

Definition of chirality Stereoisomers (enantiomers and diastereomers) Stereogenic center Axial, planar and helical chirality Topological chirality (chiral objects)

Relevance of chirality to biological activity of chemical compounds

Chiral drugs

Comparative description of methods for preparation of enantiomerically pure chiral compounds

Analytical methods for evaluation of enantiomeric purity of chiral compounds Different Biological Effects of Enantiomers

• Taste • Smell • Toxicity • Pharmacology (Thalidomide) Capillary electrophoresis (CE) is very powerful technique for analytical-scale enantioseparations

O 2 N OH ** O 1 OON HO H O trans N -5´-Hydroxythalidomide [3,4] * O cis OON -5´-Hydroxythalidomide [5,6] H 5 6 5-Hydroxythalidomide [1,2] O

N * O OON 3 H 4 Thalidomide [7,8] 7 8 UV absorbance UV absorbance at 230 nm

0 5 10 15 20 25 30 time [min] Reflections of stereochemistry in the taste of compounds Basics of Stereochemistry

Definition of chirality Stereoisomers (enantiomers and diastereomers) Stereogenic center Axial, planar and helical chirality Topological chirality (chiral objects)

Relevance of chirality to biological activity of chemical compounds

Chiral drugs

Comparative description of methods for preparation of enantiomerically pure chiral compounds

Analytical methods for evaluation of enantiomeric purity of chiral compounds Chiral Drugs “Stereochemistry of the molecule must be carefully considered in all fields of pharmaceutical sciences ranging from discovery to the bedside. An understanding of the role of chirality in the properties of the molecule of interest is undoubtedly a main key to the rational process of developing as well as clinical use of chiral drugs. Keeping in mind the issue of ‘‘racemate versus single ’’ during various steps of drug discovery and development may save money and time”.

Fakhreddin Jamali, 2004. “Driven by needs of the drug industry and fuled by the ingenuity of chemists, sales of single-enantiomer chiral compounds keep accelerating”

S.C. Stinson, C&E News, May 14, 2001.

Chiral Components Sales of enantiomeric intermediates and single-enantiomer drugs are up

ENANTIOMERIC BULK INTERMEDIATES ENANTIOMERIC DRUGS $ MILLIONS 1999 2000 2005 1999 2000 2005 Anti-inflammatory/analgesics $ 150 $ 156 $ 168 $ 200 $ 223 $ 241 Antiviral 794 830 1.643 983 1.180 2.054 Cancer 892 1.073 1.297 1.783 2.146 2.593 Cardiovascular 1.133 2.281 3.269 1.889 3.802 5.449 Central nervous system 1.038 1.142 1.821 1.483 1.632 2.602

Dermatology 82 85 106 164 170 212 Gastrointestinal 251 331 649 413 567 1.082 Ophthalmic 238 284 401 340 405 573 Respiratory 576 656 914 1.151 1.511 2.287 Other 140 170 356 315 426 891 TOTAL $ 5.294 $ 7.008 $ 10.624 $8.721 $12.062 $17.984

SOURCE: Technology Catalysts International Levalbuterol (1999) S-Cetirizine (2000)

O N N N Cl NHCHO HO N O CH3 CH3 O H C N N N 3 H O OH

S-Zopiclone (2002) R,R ´-Formoterol (2003)

O H5C6 O OH N(C2H5)2 S-Oxybutinin (2003) Cl

NH2 CH3O H N

HN O O CH 3 Ticalopride

O O N

CH3O N N O

N CH3O NH 2 (S)-Doxazosin (2004)

O N N N Cl N O d HN N SEP-174559 (2004) O

CH(CH3)2

NHCH3 Cl (S)-Sibutramine metabolite e (2004) O N N

CH3 N (R)-Ondansetron

CH3

H C N NH 3 O 2

CO C H CH3O2C 2 2 5 Cl (S)-Amlodipine

CF3

O (R)-Norfluoxetine

NH2 Structure of Protease Inhibitors for the Treatment of HIV Infection

O CH3 OH OH OH N CH3 O NH2 NH NNH OH 2 N NH N N NH CH3 O O NH N O CH3 O S O NH CH O NH 3 O O O CH H3C 3 CH3SO3H CH3 Saquinavir Indinavir Amprenavir

OH CH3 CH OH OH O S 3 O NH N HO CH3 N CH3 NH NNH ONH NHN N CH3 S NH O NH CH O O NH CH 3 S CH3 O O 3 O CH3 O H3C CH3 H3CCH3

Ritonavir Lopinavir/Ritonavir Nelfinavir

L. A. Sorbera, L. Martin, J. Casta ňer, R. M. Casta ňer, Drugs of the Future, 2001, 26, 224 Basics of Stereochemistry

Definition of chirality Stereoisomers (enantiomers and diastereomers) Stereogenic center Axial, planar and helica chirality Topological chirality (chiral objects)

Relevance of chirality to biological activity of chemical compounds

Chiral drugs

Comparative description of methods for preparation of enantiomerically pure chiral compounds

Analytical methods for evaluation of enantiomeric purity of chiral compounds Strategy and need of enantioseparation techniques in chiral drug development

Drug Required Amount Cost Importance of Development enantiomer importance scale-up step feasibility

Discovery both mg-50 g minor minor

Early both 100g-10kg minor middle Development

Full active 5-100 kg middle major Development enantiomer

Production active tons major prerequisite enantiomer Preparation methods for enantiomers

Chiral Prochiral Racemates pool compounds

Kinetic Synthesis Asymmetric synthesis resolution Scope and Limitations of Major Production Methods for Enantiomericley Pure or Enriched Molecules ------Catalysis Resolutions HPLC ------Enantioselectivity 1-2 1 1 1-2 1 Productivity 1-2 2-3 - - - Availability, diversity 1-2 2-3 2 1 1 Substrate specificity 2 3 1 1 2 Work-up, ecology 1-2 2-3 2 2 2 Development time, effort 2 3 1 1-2 1 Application in the lab 2 3 1 1-2 1 Application in development 1-2 2 1 2 2 Small scale production 1-2 1-2 1 1-2 2 Large scale production 1 2-3 2 1-2 3 ------Rating: 1-high; 2-medium/some problems; 3-low/problematic. “For products in development, the time to develop a catalytic asymmetric process may not meet the need to get materials out rapidly for testing”

A.M. Rouhi, C & EN, June 14, 2004 Chiral Pool

OH L-(+)-Tartaric acid (s) NH2

NH2

H CH2OH

H HOH C H Cl 2 Cl (s) N N (s)

H CH2OH H

(S,S)-Ethambutol Enantioselective Synthesis

OMe H C CH OMe 3 3 H C 3 CH3 OMe N O N S (i), (ii) N ----S N N OMe H N H Esomeprazole, 94.5% ee

(iii), (iv) OMe H C 3 CH3 O N ----S N OMe N Na

Esomeprazole Sodium, 99.5% ee Preparation methods for enantiomers

Chiral Prochiral Racemates pool compounds

Kinetic Crystallization Synthesis Asymmetric synthesis resolution Methods for the Resolution of Racemates

Racemates

Preferential Kinetic Diastereomeric crystallization resolution crystallization

Chemical Enzymatic Examples of Pharmaceuticals Resolved using Diastereomeric Crystallization in the Process

Pharmaceutical Resolving agent Ampicillin D-Camphorsulphonic acid Ethambutol L-(+)-Tartaric acid Chloramphenicol D-Camphorsulphonic acid Dextropropoxyphene D-Camphorsulphonic acid Fosfomycin R-(+)-Phenethylamine Thiamphenicol D-(-)-Tartaric acid Naproxen Cinchonidine cis-Diltiazem R-(+)-Phenethylamine O O Cl Cl O Cl AlCl CH HCl N + Cl 3 3 N CH3 NH CH3 (I) (III) (IV) O CH3 (II) O CH3 EtO NH NH2 Cl O NH S CH3 N (V) O heat O S O CH3 CH3 CH O CH3 O 3 O CH3 N (VII) NH N COCl O (IX) Et3N O CH3 S CH3 CH Et3N EMD-53998 O H C 3 O CH3 NH 3 CH3 1) rac-(VIII) NH chromatographic (VI) O O O chromatographic separation separation of diastereomers of enantiomers O N O NH O NH N N N S S S

CH + CH3 3 N CH3 N N O O O CH3 (X) O CH3 O CH3 O CH CH CH O 3 O 3 O 3 (-)-EMD-53998 (EMD-57439) (+)-EMD-53998 (EMD-57033)

O (XI) NH “Despite the unrelenting pace of research in catalytic asymmetric , relatively few catalytic enantioselective processes are currently operated on a commercial scale . Until more bio- and chemocatalytic chiral routes are developed that are robust and cost-effective for large-scale production, the bulk of optically pure compounds will have to be prepared through traditional chemistry, including conventional syntheses based on chiral substances or stoichiometric chiral induction and separations, such as chromatographic resolutions .”

A.M. Rouhi, C & EN, June 14, 2004 Preparative-scale Liquid-chromatographic Separation of Enantiomers Chromatographic Separation Methods useful for Preparation of Enantiomers

• Column Chromatography

• Recycling Loop Chromatography

• Simulating-Moving Bed Chromatography

• VARICOL Schematics of SMB Unit

Solid Liquid

Zone IV

Raffinate Q raf Zone III

Feed G F Zone II

Extract Q Es Zone I

Eluent Q El

SMB is a continuous separation process Selected examples of applications of SMB-chromatography for the production of enantiomerically pure compounds.

Chiral compound CSP Capacity Consumption of the mobile phase l/g Aminoglutethimide Chiralcel OJ 7.5 g/h·kg CSP 0.740 ml 1,1'Binaphthyl-2,2'-diol Pirkle-type 3,5- 2000 g was DNBPG resolved per day Chiral drug candidate Chiralpak AD ca. 30-60 g/h·kg ca. 0.190-0.380 ml (potent partial agonist at muscarinic receptors) CGS 26 214 Chiralcel OJ 47 g/d·kg 4.561 Cycloalkanone Chiralcel OC 1082 g/d·kg 0.280 DOLE Chiralcel OF 272 g/d·kg 0.440 EMD 53 986 Polyacrylamide 319 g/d·kg 2.540 Chiralpak AD 432 g/d·kg 2.600 EMD 77 697 Chiralcel OD 451 g/d·kg 1.640 EMD 122 347 Chiralpak AD 311 g/d·kg 0.590 Formoterol Chiralcel OJ 1.2 g/h·kg 0.515 Hetrazepine Cellulose 119 g/h·kg 0.094 triacetate (CTA) Guaifenesin Chiralcel OD 10.0 g/h·kg 0.380 Oxo-oxazolidine L-Chiraspher 6.8 g/h·kg 0.900 Phenylethylalcohol Chiralcel OD 0.98 g/L 5.300 Praziquantel CTA 4.7 g/h·kg 0.056 Propranolol Chiralcel OD 3.83 g/h·kg 0.200 Sandoz-epoxide CTA 59 g/d·kg 0.800 Sandoz-epoxide Chiralcel OD 37 g/d·kg 0.500 1a, 2, 7, 7a-Tetrahydro- CTA 1.45 g/h·kg 0.400 3-methoxy-napht(2,3-6) oxirane Threonine Chirosolve L- 30 g was proline resolved Tramadol Chiralpak AD 50 g/h·kg 0.500 Wieland-Mieschler Chiralpak AD 84 g/h·kg 0.490 Ketone

Loadability of Chiral Stationary Phases

100 mg/g CSP Protein-based CSPs Vancomycin CSP 50 Cyclodextrin-based CSPs 10 Tetraamide CSPs (Kromasil 5.0 Polyacrylamide (Chiraspher) Brush-type CSPs (Pirkle) 1.0 Polysacchiride-based CSPs 0.5 0.1 Basics of Stereochemistry

Definition of chirality Stereoisomers (enantiomers and diastereomers) Stereogenic center Axial, planar and helica chirality Topological chirality (chiral objects)

Relevance of chirality to biological activity of chemical compounds

Chiral drugs

Comparative description of methods for preparation of enantiomerically pure chiral compounds

Analytical methods for evaluation of enantiomeric purity of chiral compounds “Good analytics are crucial with any project. If they are not reliable or are slower than the throughput of screening systems, they are useless”

A.M. Rouhi, C &EN, June 14. 2004. Major Techniques Available for Separation of Enantiomers

Gas Chromatography (GC)

High Performance Liquid Chromatography (HPLC)

Capillary Electrophoresis (CE)

Capillary Electrochromatography (CEC)

Supercritical Fluid Chromatography (SFC) Gas Chromatography

Advantages:

Relatively high peak efficiency

Disadvantages:

Applicable only for thermostable and volatile compounds

Limited variaty of available stationary phases

No flexibility from the viewpoint of selectivity adjustment based on the mobile phase

Not easy to be applied for preparative separations High-Performance Liquid Chromatography (HPLC) Advantages:

Applicable for thermolabile and nonvolatile compounds

Wide variety of stationary phases are available

Selectivity can be adjusted based on the mobile phase

Applicable for preparative scale separations

Disadvantage

Lower plate numbers than in oter separation techniques (GC, SFC and CE) Stationary Phases Available for HPLC Enantioseparations

Pirkle (Brush) type chiral selectors

Proteins

Cyclodextrines (Cyclofructans)

Synthetic chiral polymers (polyacrilamides, polymethacrylates)

Macrocyclic antibiotics

Cinchona alkaloids

Polysaccharides Why shall we use polysaccharide derivatives as chiral stationary phases (CSP) in liquid phase separation techniques?

• Polysaccharide based materials are rather universal CSPs

• These materials can be used with normal-, reversed- and polar organic mobile phases

• Applicable for both pressure and voltage-driven separations

• Extremely high enantioselectivity can be achieved using these CSPs for various group of analytes

• A large family of polysaccharide-based CSPs are available

• Polysaccharide-based CSPs are very useful for preparative and product scale enantioseparations Loadability of Chiral Stationary Phases

100 mg/g CSP Protein-based CSPs Vancomycin CSP 50 Cyclodextrin-based CSPs 10 Tetraamide CSPs (Kromasil 5.0 Polyacrylamide (Chiraspher) Brush-type CSPs (Pirkle) 1.0 Polysacchiride-based CSPs 0.5 0.1 Super/Sub-critical Fluid Chromatography (SFC) Advantages:

Higher plate numbers than in HPLC (but lower than in GC and CE)

Applicable for thermolabile and nonvolatile compounds

Applicable for preparative separations

Uses HPLC stationary phases

Green(er) technology

Disadvantages:

No alternative (its own) separation principle

Lower flexibility from the viewpoint of mobile phases Capillary Electrophoresis Advantages:

Alternative separation mechanism

Very high plate numbers

Various chiral selectors available

High flexibility from the viewpoint of adjustment of selectivity (and enantiomer migration order

Miniaturized technique

Disadvantages:

May require special skills on order to achieve required reproducibility/repeatability

Not applicable for gaseous molecules

Not applicable for preparative separations Separation Technology

Chiral Selector

Carrier

Mobile Phase Major Liquid-phase Instrumental Techniques Available for Separation of Enantiomers

High Performance Liquid Chromatography (HPLC)

Supercritical Fluid Chromatography (SFC)

Capillary Electrophoresis (CE)

Capillary Electrochromatography (CEC)

(Microfabricated devices) Buffer reservoirs CZE

Flow profiles in chromatography and CE

Parabolic flow Chromatography

Plug-like flow Electrodriven techniques

Narrow peaks Capillary electrophoresis (CE) is very powerful technique for analytical-scale enantioseparations

O 2 N OH ** O 1 OON HO H O trans N -5´-Hydroxythalidomide [3,4] * O cis OON -5´-Hydroxythalidomide [5,6] H 5 6 5-Hydroxythalidomide [1,2] O

N * O OON 3 H 4 Thalidomide [7,8] 7 8 UV absorbance UV absorbance at 230 nm

0 5 10 15 20 25 30 time [min] Enantioseparation of meptazinol with βββ-CD column in HPLC and simultaneous enantioseparation of meptazinol and metabolites in CE using βββ-CD as a chiral selector -4

Meptazinol 10 3-Hydroxyehtyl- OH 40 (-) meptazinol (+)

CH CH 30 N-Desmethyl- 2 3 Absorbance meptazinol Meptazinol N CH 3 20 (-)(+)

10

0 20 60 100 10 Time, (min) Time, (min) Capillary electrophoresis is very powerful technique not only for analytical scale enantioseparations but also for investigation of fine mechanisms of enantioselective intermolecular interactions. Advantages of CE for Separation of Enantiomers

CE allows very fast screening of selector-select and interactions in order to prevail the most promising chiral selector. There is no other instrumental separation or non-separation technique that may compete with CE in this respect.

The high peak efficiency in CE permits to observe (enantio)selective features in selector-selectand interactions which are invisible by other (separation) techniques.

A small thermodynamic selectivity of recognition can be transformed into a high separation factor in CE.

CE is more flexible than chromatographic techniques in order to adjust the (enantio)separation factor

Combination of chiral selectors is much easier in CE than in HPLC. Techiques Available for Mechanistic Studies Related to Chiral CE: 1. X- ray crystallography (Provides information about most likely stoichiometry and structure of selector-selectand complex but in the solid state)

2. NMR spectroscopy (Provides information about the stoichiometry, binding constants and structure of selector-selectand associates in solution but is not suitable for mixed complexes)

3. Mass Spectrometry (Provides information about the stoichiometry and the binding constants of selector-selectand complexes and is also suitable for mixed complexes)

4. Molecular Modeling/Mechanics Calculations (May allow to calculate major forces involved in intermolecular interactions and in chiral recognition) X-Ray Structure of the Complexes of brompheniramine maleate with βββ-CD (a) and heptakis-(2,3,6-tri-O-methyl )-βββ-CD (b)

10 -3 -3 30 10 TM-β-CD S β-CD S 20 20 R 15 R

10 10 5

0 0 12 13 14 15 16 14 18 22 26 30 Time (min) Time (min) Affinity of Aminoglutethimide Enantiomers Towards Native Cyclodextrins (ααα, βββ, γγγ)

α β γ H1-NMR spectra of (±)-aminoglutethamide complexes with ααα-, βββ-, and γγγ-CDs

a)

b)

c) βββ-CD/ aminoglutethimide Complex

meta

ortho O6 C6

O5 C5 H5 C1 C4

C2 H3 C3

O2 O3

βββ-Cyclodextrin/aminoglutethimide Complex γγγ- CD/aminoglutethimide Complex

ortho meta

meta ortho O6 C6

O5 C5 H5 C1 C4 H3 C2 C3

O2 O3

γγγ-Cyclodextrin/aminoglutethimide Complex CE Enantioseparation and the Structure of Complexes Between aminoglutethimide and βββ- and γγγ-cyclodextrins

Aminoglutethimide

O6 O6 C6 C6

O5 C5 O5 C5 H5 H5 C1 C4 C1 C4 γγγ−γ−−−CD H3 C2 βββ-CD H3 C3 C2 C3

O2 O3 O2 O3 1D-ROESY Spectrum of (+/-)- clenbuterol Complex with βββ-CD

βββ-CD O6 H-1 C(CH 3)3 H-6 C6 H-3 H-4 O5 C5 Har H-5 H-2 H5 CH 2 C1 C4

C2 H3 C3

O2 O3 C(CH 3)3

CH 2

CH 2

Har

ppm 7.1 4.6 3.3 2.9 1.2 1D-ROESY spectrum of (+/-)- clenbuterol complex with HDA-βββ-CD HDA-βββ-CD H-1 H-5H-4 COCH 3 O6 C6 H H-3 C(CH ) ar H-2 3 3 H-6 H-6´ O5 C5 H5 CH 2 C1 C4 H3 C2 C3

O2 O3 C(CH 3)3 C7 C8

C(CH 3)3

CH 2

Har

ppm 7.1 3.9 3.0 1.9 1.2 1D-ROESY spectrum of (+/-)-clenbuterol complex with HDA-βββ-CD

H-5/H-4 COCH 3 H H-3 H-1 ar H-2 H-6 H-6´ C(CH 3)3 CH 2

HDA-βββ-CD O6 C6 COCH 3 O5 C5 H5 C1 C4 (H-5)+(H-4) H3 C2 C3

H-6´ O2 O3 C7 C8 H-6

H-2

H-1

H-3 Enantioseparation of clenbuterol with βββ-CD and heptakis-(2,3-diacetyl-βββ-CD) and structure of intermolecular complexes in solution HDA-βββ-CD βββ-CD O6 O6 C6 C6

O5 C5 O5 C5 H5 H5 C1 C4 C1 C4 H3 H3 C2 C3 C2 C3

O2 O3 O2 O3 C7 C8

-3 10 10 -3 30 S S 20

20 R R

10 10

0 0

12 14 16 14 22 30 Time (min) Time (min) Clenbuterol MM+ Optimized Structure of clenbuterol/ βββ-CD Complex MM+ Optimized Structure of clenbuterol/ βββ-CD Complex MM+ optimized structure of clenbuterol/HDA-βββ-CD complex MM+ optimized structure of clenbuterol/HDA-βββ-CD c omplex 15 mM HDMS-β-CD 25 mM HDAS-β-CD 18 12 Normal Normal polarity 16 10 d) non-aqueous a) aqueous S polarity 14 8 S

12 6 10 4 R

R mAU mAU 8 2 6 0 4

-2 2

0 -4 6 7 8 9 10 11 12 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 Time (min) Time (min) H1 H1

H2 H1 H3 H3

H4 H2 H5 H5 H3 H3

H4

H6 H5 H5

H6 Electrophoresis, 2010, 31, 1667-1674 J. Sep. Sci., 2010, 33, 1617-1624 Correlations Between Structure and Binding (Nonaqueous medium)

R-Propranolol/HDAS-βββ-CD S-Propranolol/HDAS-βββ-CD 1 2

1 0

8 S 6 R

4 mAU

2

0

-2

-4 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 Tim e (m in) Major Liquid-phase Instrumental Techniques Available for Separation of Enantiomers

High Performance Liquid Chromatography (HPLC)

Supercritical Fluid Chromatography (SFC)

Capillary Electrophoresis (CE)

Capillary Electrochromatography (CEC)

(Microfabricated devices) Capillary Electrochromatography

• o-CEC (open tubular capillary electrochromatography)

• p-CEC (packed capillary electrochromatography)

• rod-CEC (monolithic capillary electrochromatography) p-CEC

•Combines selectivity of LC and efficiency of CE • Applicable for neutral compounds Pore structure and particle size of packing material Scanning electron microscopy (SEM) Monolithic columns for CEC

• Inorganic (silica-based) monoliths

• Organic Monoliths

• Hybrid Organic-inorganic monoliths 100 µm ID monolithic silica capillary before and after modification with polysaccharide derivative CLC vs. CEC

(+)-piprozolin Capillary LC (-)-piprozolin Capillary LC CEC CEC 40 40 HETP HETP (µm) HETP HETP (µm)

20 20

0 0 0 1 2 0 1 2 Linear flow velocity (mm/sec ) Linear flow velocity (mm/sec)

2.5mM ammonium acetate. in MeOH Native silica- 2000 Å, 5µm , 5% CDCPC

♦At the optimal flow rate peak efficiency in CEC is at least two times higher compared to capillary LC

♦ CEC tolerates high linear flow velocities much better than capillary LC Does CEC offer higher peak efficiency compared to CLC under identical conditions?

O

S b) CEC: -5 kV a) Capillary LC: 12 bar inlet vial NH 2 C N1: 160061/m O N2: 154852/m R : 1.65 2-Benzylsulfinylbenzamide S CLC CEC mAU mAU

200 80

100 40

0 5 10 15 20 0 5 10 15 20 time (min) time (min) CLC vs. CEC

(+)-piprozolin Capillary LC (-)-piprozolin Capillary LC CEC CEC 40 40 HETP HETP (µm) HETP HETP (µm)

20 20

0 0 0 1 2 0 1 2 Linear flow velocity (mm/sec ) Linear flow velocity (mm/sec)

2.5mM ammonium acetate. in MeOH Native silica- 2000 Å, 5µm, 5% CDCPC

♦At the optimal flow rate peak efficiency in CEC is at least two times higher compared to capillary LC

♦ CEC tolerates high linear flow velocities much better than capillary LC Fast Enantioseparation of ( ±±±)-piprozolin in CEC

(-)-Piprozolin

S N OC2H5 (+)-Piprozolin * N O O

CH3

-1 N1=168 750 m -1 Thiourea N2=117 400 m

0.5 1 Time (min)

5% CDCPC, CSP : Aminopropylsilanized silica gel (2000 Å, 5 µµµm), 8.5 cm packed bed. Buffer: 10 mM ammonium acetate; Applied voltage: 25 kV Enantioseparation of thalidomide and its metabolites in CLC and CEC CLC (13 bar) CEC (20 kV) Absorbance 5-OH 5-OH 5-OH Absorbance 5-OH Thalidomide Thalidomide 5'-OH Thalidomide 5'-OH + 5'-OH Thalidomide 5{'-OH

20 30 40 50 Time (min) 10 25 40 Time (min)

Separation conditions: 25 % (OD+AD), native silica 2000 Å, 5 µm. Buffer: 10 mM ammonium acetate in (MeOH+EtOH (55/45).